✦ LIBER ✦

A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer

✍ Scribed by Jouve, M.; Dorval, T.; Mosseri, V.; Palangie, T.; Beuzeboc, P.; Garcia-Giralt, E.; Livartowski, A.; Scholl, S.; Pouillart, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oral etoposide for pat

✍ Daniel M. Atienza; Charles L. Vogel; Bruce Trock; Sandra M. Swain 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

Phase I–II study of high-dose etoposide

✍ Giuseppe Fraschini; Frankie A. Holmes; Laura Esparza; Richard L. Theriault; Aman 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 162 KB

Phase II multicentre study of docetaxel

✍ del Muro, X García; Marcuello, E; Gumá, J; Paz-Ares, L; Climent, M A; Carles, J; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

Cisplatin and 5-fluorouracil in refracto

✍ Domenico Amoroso; Paolo Pronzato; Gianfilippo Bertelli; Pietro Gallotti; Gisella 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 233 KB

Phase II study with etoposide in previou

✍ Hans-Erik Wander; Winrich Rauschning; Dirk Meyer; Wolfgang Achterrath; Gerd-Arno 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 281 KB

PR90 ETOPOSIDE PLUS CISPLATIN COMBINATIO

✍ Ahn, Byong Hyon; Chang, Eil Sung 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB